> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Records Updated to Reflect EUAs for 2 Biologics
- URL: https://www.fdaweb.com/records-updated-to-reflect-euas-for-2-biologics/
- Published: 2021-05-26T12:00:00.000Z
- Updated: 2026-09-14T17:00:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149405

*Federal Register* notice: FDA is updating its administrative records to reflect two Emergency Use Authorizations (EUAs) (XXX PLURAL XXX)for biological products for use during the Covid-19 pandemic. On 2/9, an EUA was granted to Eli Lilly for bamlanivimab and etesevimab combination use, and on 2/27, an EUA was granted to Janssen Biotech for its Covid‑19 vaccine. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-11234.pdf?ref=fdaweb.com).